Pharmaceutical Commerce - October 2025

View the Pharmaceutical Commerce October 2025 issue in an interactive format.

Explore the latest innovative strategies and insider perspectives on cold chain management and sustainable packaging in the October issue of Pharmaceutical Commerce.

Introducing our deep dive into the state of biopharma at the moment—directly from the voices of those decision-makers most impacted by the current industry volatility.

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

This first-party approach to data-driven messaging can ensure timely, compliant, and personalized engagement with healthcare providers at the point of care.

How can 360° connectivity drive pharma innovation?

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

As the sentiment of surveyed dangerous goods experts backs up, updated packaging pursuits can boost efficiency and cut costs—while mitigating the environmental impact.

Amid intensified competition—and evolving IRA and PBM dynamics—leaders in the access space must now adopt a strategist mindset.

Companies must assess illicit trade risks under a new EU directive, making materiality and compliance critical for sustainability reporting.

Marketed as cost-saving tools, AFPs can also strain safety-net resources.

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Amid pressures on pharma to match the lowest international prices, experts warn of “policy laundering” and discriminatory impact.

Capturing insights from executives and industry experts on the biggest challenges shaping pharma today, from drug pricing pressures and access barriers to supply chain shifts, digital adoption, and evolving patient-centered care strategies.

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.